Evidence map›Paper›PMID 29802408›Full record

ArticleNature cell biology2018

Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis.

Melissa Q Reeves, Eve Kandyba, Sophie Harris, Reyno Del Rosario, Allan Balmain

Abstract read
In one paragraph

Article in Nature cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instability.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Genetic evolution of keratinocytes to cutaneous squamous cell carcinoma.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Melissa Q ReevesHelen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA. Melissa.Reeves@ucsf.edu.ORCID http://orcid.org/0000-0002-4886-5164
Eve KandybaHelen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA.
Sophie HarrisHelen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA.
Reyno Del RosarioHelen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA.
Allan BalmainHelen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA. Allan.Balmain@ucsf.edu.ORCID http://orcid.org/0000-0001-6549-7861

Funding

Systems genetics analysis of tumor evolution in the mouseR35CA210018 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALLAN BALMAIN · 2017 to 2026
$8.0M
PREDOCTORAL TRAINING IN BIOMEDICAL SCIENCEST32GM008568 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANSEL, KARL MARK · 1995 to 2019
$6.3M
Integrating targeted and immunotherapy to treat genetically heterogeneous cancersU01CA217864 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALMAIN, ALLAN, KRUMMEL, MATTHEW F · 2017 to 2021
$5.1M
Genetic network analysis of cancer targetsU01CA176287 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2013 to 2016
$1.2M
Genetic analysis of ras mutation specificity in skin and lung cancerR01CA184510 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALMAIN, ALLAN · 2015 to 2017
$1.1M
Clonal evolution of carcinomas from initiation to metastasisF31CA206459 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI REEVES, MELISSA QUINO · 2016 to 2017
$40k
NCI NIH HHS F31 CA206459NCI NIH HHS R01 CA184510NCI NIH HHS R35 CA210018NCI NIH HHS U01 CA176287NCI NIH HHS U01 CA217864NIGMS NIH HHS T32 GM008568
6 · The paper itself

Abstract

Tumour cells are subjected to evolutionary selection pressures during progression from initiation to metastasis. We analysed the clonal evolution of squamous skin carcinomas induced by DMBA/TPA treatment using the K5CreER-Confetti mouse and stage-specific lineage tracing. We show that benign tumours are polyclonal, but only one population contains the Hras driver mutation. Thus, benign papillomas are monoclonal in origin but recruit neighbouring epithelial cells during growth. Papillomas that never progress to malignancy retain several distinct clones, whereas progression to carcinoma is associated with a clonal sweep. Newly generated clones within carcinomas demonstrate intratumoural invasion and clonal intermixing, often giving rise to metastases containing two or more distinct clones derived from the matched primary tumour. These data demonstrate that late-stage tumour progression and dissemination are governed by evolutionary selection pressures that operate at a multicellular level and, therefore, differ from the clonal events that drive initiation and the benign-malignant transition.

Indexed as

Cell LineageClonal Evolution9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinoma, Squamous CellCell MovementCell ProliferationCell Transformation, NeoplasticEpithelial CellsFemaleGene Expression Regulation, NeoplasticGenes, rasGenetic Predisposition to DiseaseMaleMice, TransgenicMutation9,10-Dimethyl-1,2-benzanthraceneTetradecanoylphorbol Acetate

Identifiers

PMID29802408
PMCPMC6400587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.